Skip to main content

Table 1 Clinical characteristics and summary findings of these ASD or ADHD studies included in this meta-analysis

From: Common and distinct cortical thickness alterations in youth with autism spectrum disorder and attention-deficit/hyperactivity disorder

Study

Dataset

Patients

Typically developing controls

Methods

Summary findings

Number (male)

Mean age (SD), years

Mean IQ (SD)

Comorbidity

Medication status (%)a

Number (male)

Mean age (SD), years

Mean IQ (SD)

Preprocessing

Statistical threshold

Field strength

 

ASD studies

 Raznahan et al. (2013) [30]

 

66 (66)

3.8 (1.0)

NA

NA

NA

29 (29)

3.8 (1.1)

NA

CIVET

p < 0.05 (corrected)

1.5 T

ASD > TDC: L SFG, superior temporal sulcus; R SFG, MFG, superior temporal sulcus, rostral intraparietal sulcus

 Duerden et al. (2013) [31]

 

33 (29)

10.7 (2.5)

104.0 (18.3)

NA

Medication-free

30 (26)

10.7 (2.5)

113.6 (13.7)

CIVET

p < 0.05 (corrected)

1.5 T

-

 Schaer et al. (2013) [32]

 

11 (8)

12.9 (2.7)

79.4 (18.1)

NA

NA

11 (8)

12.7 (2.7)

110.5 (13.3)

Freesurfer

p < 0.05 (corrected)

3.0 T

-

 Dierker et al. (2015) [33]

 

34 (28)

11.4 (1.9)

111.5 (12.5)

NA

NA

32 (23)

11.3 (1.8)

114.9 (11.3)

Freesurfer

p < 0.025 (corrected)

3.0 T

-

 Foster et al. (2015) [9]

 

38 (38)

12.4 (2.4)

102.5 (17.0)

Pure

NA

46 (46)

12.6 (2.6)

113.1 (12.0)

CIVET

p < 0.001 (uncorrected)

3.0 T

ASD > TDC: L IFG;

ASD < TDC: R angular gyrus

 Sussman et al. (2015) [34]

 

72 (61)

NA

NA

NA

NA

138 (116)

NA

NA

CIVET

p < 0.05 (corrected)

3.0 T

-

 Yang et al. (2016) [35]

 

60 (60)

8.4 (2.1)

103.1 (14.5)

NA

NA

41 (41)

8.8 (2.3)

107.0 (15.0)

Freesurfer

p < 0.05 (corrected)

3.0 T

-

 Tanigawa et al. (2018) [36]

 

16 (16)

13.4 (1.1)

112.7 (13.8)

Pure

NA

17 (17)

13.4 (1.2)

118.4 (15.0)

Freesurfer

p < 0.01 (corrected)

3.0 T

-

 Kohli et al. (2019) [37]

Data from SDSU

64 (52)

13.3 (2.7)

106.7 (16.9)

NA

NA

64 (55)

13.5 (3.0)

106.5 (14.1)

Freesurfer

p < 0.01 (corrected)

3.0 T

ASD < TDC: R insula

 

Data from NYU

31 (31)

11.4 (2.8)

103.2 (10.1)

NA

NA

31 (31)

11.8 (2.6)

110.5 (11.9)

Freesurfer

p < 0.01 (corrected)

3.0 T

-

 Yin et al. (2022) [38]

Data from SI

18 (12)

12.0 (3.5)

99.9 (18.8)

ADHD, anxiety disorder

NA

18 (12)

12.7 (NA)

NA

Freesurfer

p < 0.05 (corrected)

1.5 T

-

 

Data from RU

15 (12)

12.7 (4.6)

100.9 (14.4)

ADHD, anxiety disorder

NA

15 (8)

10.9 (NA)

NA

Freesurfer

p < 0.05 (corrected)

3.0 T

-

ADHD studies

 Qiu et al. (2011) [39]

 

15 (15)

12.7 (1.8)

NA

Pure

Medication-free

15 (15)

13.2 (1.7)

NA

Freesurfer

p < 0.05 (uncorrected)

3.0 T

ADHD < TDC: R frontal lobe, L frontal lobe, R cingulate cortex

 de Zeeuw et al. (2012) [40]

 

99 (87)

10.5 (2.0)

101.6 (16.0)

ODD, CD

Medication-free

101 (85)

10.1 (1.8)

106.0 (12.9)

CLASPb

p < 0.05 (corrected)

1.5 T

-

 Hoekzema et al. (2012) [41]

 

43 (35)

11.6 (2.9)

NA

Pure

Medicated (88%)

41 (28)

11.2 (3.0)

NA

Freesurfer

p < 0.05 (corrected)

1.5 T

ADHD < TDC: L IPL, lingual gyrus, pre-CG, OFG; R pre-CG, OFG, IPL

 Saute et al. (2014) [42]

 

18 (11)

12.1 (3.2)

93.4 (9.2)

Epilepsy

Medicated (39%)

46 (19)

13.1 (3.3)

110.2 (11.2)

Freesurfer

p < 0.05 (corrected)

1.5 T

ADHD < TDC: L SPL, para-CG, insula; R IPL, pars opercularis, SFG

 Colak et al. (2019) [43]

 

13 (13)

16.0 (1.2)

NA

Pure

Medication-free

13 (13)

16.5 (1.3)

NA

Freesurfer

p < 0.05 (corrected)

3.0 T

ADHD < TDC: L caudal MFG, R pre-CG

 Lu et al. (2019) [44]

 

53 (53)

10.4 (2.1)

104.0 (5.1)

Pure

Mediation-naïve

53 (53)

10.9 (2.3)

107.6 (6.6)

Freesurfer

p < 0.05 (corrected)

3.0 T

-

 Vetter et al. (2020) [45]

Pure ADHD

36 (36)

13.0 (1.6)

107.0 (8.0)

Pure

Medication-free

30 (30)

13.6 (1.6)

110.0 (8.0)

Freesurfer

p < 0.05 (corrected)

3.0 T

-

 

ADHD + ODD/CD

26 (26)

13.0 (1.2)

106.0 (13.0)

ODD, CD

Medication-free

30 (30)

13.6 (1.6)

110.0 (8.0)

Freesurfer

p < 0.05 (corrected)

3.0 T

ADHD > TDC: R rostral MFG

 Lee et al. (2021) [46]

 

19 (14)

13.5 (0.9)

113.8 (11.5)

Pure

Medicated (100%)

20 (11)

13.4 (1.2)

110.7 (15.2)

Freesurfer

p < 0.05 (corrected)

3.0 T

-

 Sarabin et al. (2023) [47]

 

61 (36)

9.9 (0.7)

NA

behavioral disorder, anxiety disorder

NA

61 (38)

10.0 (0.7)

NA

Freesurfer

p < 0.05 (corrected)

3.0 T

-

  1. ASD Autistic spectrum disorder, ADHD Attention-deficit and hyperactivity disorder, TDC Typically developing controls, IQ Intelligence quotient, SD Standard deviation, NA Not available, T Tesla, CIVET Contentious incident variable entry template, SDSU San Diego State University, NYU New York University, SI Staten Island, RU Rutgers University Brain Imaging Centre, ODD Oppositional defiant disorder, CD Conduct disorder, L Left, R Right, SFG Superior frontal gyrus, MFG Middle frontal gyrus, IFG Inferior frontal gyrus, IPL Inferior parietal lobule, pre-CG Precentral gyrus, OFG Orbitofrontal gyrus, SPL Superior parietal lobule, para-CG Paracentral gyrus, CLASP Constrained Laplacian Anatomical Segmentation using Proximities
  2. a “Medication-free” represents patients in the study who were taken off medication prior to scanning. “Medication-naive” represents patients who had never been pharmacologically treated
  3. b “CLASP” is the core algorithm for generating the surfaces of gray and white matter in “CIVET” pipeline